DrugCite
Search

KW 0761

Adverse Events
Drug Profile
Learn More
Reference
About Results
Comments

Kw 0761 Adverse Events Reported to the FDA Over Time

How are Kw 0761 adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Kw 0761, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Kw 0761 is flagged as the suspect drug causing the adverse event.

Most Common Kw 0761 Adverse Events Reported to the FDA

What are the most common Kw 0761 adverse events reported to the FDA?

Pneumonia
8 (7.34%)
Interstitial Lung Disease
4 (3.67%)
Dry Skin
3 (2.75%)
Encephalitis Viral
3 (2.75%)
Pneumonia Cytomegaloviral
3 (2.75%)
Septic Shock
3 (2.75%)
Bile Duct Stone
2 (1.83%)
Biliary Colic
2 (1.83%)
Cholecystitis
2 (1.83%)
Cytomegalovirus Infection
2 (1.83%)
Erythema
2 (1.83%)
Show More Show More
Herpes Oesophagitis
2 (1.83%)
Ileus Paralytic
2 (1.83%)
Oedema Peripheral
2 (1.83%)
Oral Candidiasis
2 (1.83%)
Skin Candida
2 (1.83%)
Toxic Skin Eruption
2 (1.83%)
Viral Haemorrhagic Cystitis
2 (1.83%)
Acne
1 (.92%)
Alanine Aminotransferase Increased
1 (.92%)
Alopecia
1 (.92%)
Arthralgia
1 (.92%)
Bacteraemia
1 (.92%)
Bacterial Infection
1 (.92%)
Blood Albumin Decreased
1 (.92%)
Blood Bilirubin Increased
1 (.92%)
Blood Calcium Decreased
1 (.92%)
Blood Creatinine Increased
1 (.92%)
Blood Lactate Dehydrogenase Increas...
1 (.92%)
Blood Phosphorus Decreased
1 (.92%)
Blood Potassium Increased
1 (.92%)
Blood Sodium Decreased
1 (.92%)
Blood Urea Increased
1 (.92%)
Blood Uric Acid Increased
1 (.92%)
Chest Pain
1 (.92%)
Cholelithiasis
1 (.92%)
Cytomegalovirus Viraemia
1 (.92%)
Decreased Appetite
1 (.92%)
Dehydration
1 (.92%)
Dermatitis Contact
1 (.92%)
Diarrhoea
1 (.92%)
Dry Eye
1 (.92%)
Ear Discomfort
1 (.92%)
Encephalitis Herpes
1 (.92%)
Febrile Neutropenia
1 (.92%)
Folliculitis
1 (.92%)
Herpes Zoster
1 (.92%)
Hyperglycaemia
1 (.92%)
Hypophagia
1 (.92%)
Laceration
1 (.92%)
Leukopenia
1 (.92%)
Liver Injury
1 (.92%)
Lung Infiltration
1 (.92%)
Lymphopenia
1 (.92%)
Nausea
1 (.92%)
Neutropenia
1 (.92%)
Oedema
1 (.92%)
Oedema Genital
1 (.92%)
Oropharyngeal Pain
1 (.92%)
Pain
1 (.92%)
Parotid Gland Enlargement
1 (.92%)
Platelet Count Decreased
1 (.92%)
Productive Cough
1 (.92%)
Purpura
1 (.92%)
Pyrexia
1 (.92%)
Rash Generalised
1 (.92%)
Rash Papular
1 (.92%)
Renal Impairment
1 (.92%)
Scab
1 (.92%)
Sensory Disturbance
1 (.92%)
Skin Erosion
1 (.92%)
Skin Exfoliation
1 (.92%)
Skin Ulcer
1 (.92%)
Stress Ulcer
1 (.92%)
Thirst
1 (.92%)
Thrombocytopenia
1 (.92%)
Upper Respiratory Tract Infection
1 (.92%)
Vomiting
1 (.92%)
Weight Decreased
1 (.92%)

ExportShare/Embed GraphExport Export Data

This graph shows the top adverse events submitted to the FDA for Kw 0761, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Kw 0761 is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Kw 0761

What are the most common Kw 0761 adverse events reported to the FDA?

Show More Show More

ExportShare/Embed Graph Export Export Data

This graph shows the top categories of adverse events submitted to the FDA for Kw 0761, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Kw 0761 is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Common Uses of Kw 0761 According to Those Reporting Adverse Events

Why are people taking Kw 0761, according to those reporting adverse events to the FDA?

Adult T-cell Lymphoma/leukaemia
24
Anaplastic Large Cell Lymphoma T- A...
1
Lymphoma
1

Kw 0761 Case Reports

What Kw 0761 safety concerns are being reported by doctors and researchers in the medical literature?

Powered by Google

About Results

This report contains aggregated drug side effects and adverse events for Kw 0761. The data has been pulled from the United States Food and Drug Administration's (US FDA) Adverse Event Reporting System (AERS), a database containing more than 4,000,000 adverse event reports.

DrugCite expands your query using the Unified Medical Language System (UMLS) to include generic drugs and primary active ingredients. While the core of DrugCite's advanced drug filtering algorithm is based on the industry standard UMLS, DrugCite's proprietary filtering system also includes dozens of additional steps to reconcile malformed drug names in the FDA's data.

DrugCite only counts a drug if the submitter of the adverse event indicates that the drug is suspected to have caused the adverse event.

Depending on how the data is aggregated, different counts may occur. When someone submits an adverse event to the FDA, the submitter can attribute multiple adverse events to one or more drugs. For example, an individual taking Paxil could submit the adverse events "anxiety" and "suicidal ideation" for the same individual safety report (ISR). This means when DrugCite aggregates by adverse event, two distinct adverse events are counted in the adverse event graph; once for "anxiety" and again for "suicidal ideation". However, when DrugCite aggregates by individual safety reports irrespective of the details of the adverse events contained within the safety report, the report is only counted once.

Comments

Share your experience with Kw 0761.